KELSEY SMITH: Open Payments
NPI 1417401720 · LAGRANGE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$963 in 44 payments from 11 companies in 2025. Trend: 2023 $706 · 2024 $1,074 · 2025 $963
Food & beverage: $863Education: $100
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $508 |
| Janssen Biotech, Inc. | 3 | $130 |
| ABBVIE INC. | 5 | $84 |
| UCB, Inc. | 3 | $52 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Mallinckrodt Hospital Products Inc. | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $26 |
| Janssen Pharmaceuticals, Inc | 2 | $23 |
| Bioventus LLC | 1 | $21 |
| ABIOMED | 1 | $20 |
Products named: KRYSTEXXA, TREMFYA, OTEZLA, RINVOQ, Bimzelx, BENLYSTA, ACTHAR, TAVNEOS.
Industry payments across GA — which companies pay providers there.
